Relapsed/refractory osteosarcoma, High-grade osteosarcoma research hub

A randomized phase II study comparing the safety and efficacy of mifamurtide and standard therapy containing sorafenib in pediatric and young adult patients with high-risk osteosarcoma

This study looks at a new treatment called mifamurtide alongside standard care for young people with a type of bone cancer called osteosarcoma that has come back or is hard to treat. It aims to see if this new combination is safe and works better.